Russia's economic crisis hits cancer treatment as oncology drug prices soar

Cancer treatment costs in Russia have risen sharply due to price increases for oncology drugs, higher import expenses and general medical-sector inflation, insurance company representatives told the newspaper Izvestia. Industry insiders describe a "spiral deepening the problem." The situation reflects the broader economic crisis driven by sanctions and war.